Thromboembolic disease in advanced colorectal cancer treated with chemotherapy and bevacizumab: a case of real "pan-thrombosis"

被引:1
作者
Giuliani, Jacopo [1 ]
Martelli, Salvatore [2 ]
Piacentini, Paolo [1 ]
Bonetti, Andrea [1 ]
机构
[1] ASL 21 Reg Veneto, Dept Oncol, Mater Salutis Hosp, I-37045 Legnago Verona, Italy
[2] ASL 21 Reg Veneto, Dept Radiol, Mater Salutis Hosp, I-37045 Legnago Verona, Italy
关键词
PLUS BEVACIZUMAB; POOLED ANALYSIS; OXALIPLATIN; FLUOROURACIL; LEUCOVORIN; THERAPY; EVENTS;
D O I
10.5301/tj.5000258
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:E32 / E33
页数:2
相关论文
共 50 条
  • [41] Plasma Protein Biomarkers in Advanced or Metastatic Colorectal Cancer Patients Receiving Chemotherapy With Bevacizumab or Cetuximab: Results from CALGB 80405 (Alliance)
    Nixon, Andrew B.
    Sibley, Alexander B.
    Liu, Yingmiao
    Hatch, Ace J.
    Jiang, Chen
    Mulkey, Flora
    Starr, Mark D.
    Brady, John C.
    Niedzwiecki, Donna
    Venook, Alan P.
    Baez-Diaz, Luis
    Lenz, Heinz-Josef
    O'Neil, Bert H.
    Innocenti, Federico
    Meyerhardt, Jeffrey A.
    O'Reilly, Eileen M.
    Owzar, Kouros
    Hurwitz, Herbert, I
    [J]. CLINICAL CANCER RESEARCH, 2022, 28 (13) : 2779 - 2788
  • [42] Addition of bevacizumab to first-line chemotherapy in advanced colorectal cancer: a systematic review and meta-analysis, with emphasis on chemotherapy subgroups
    Ligia Traldi Macedo
    Andre Bacellar da Costa Lima
    Andre Deeke Sasse
    [J]. BMC Cancer, 12
  • [43] Effects of bevacizumab on plasma concentration of irinotecan and its metabolites in advanced colorectal cancer patients receiving FOLFIRI with bevacizumab as second-line chemotherapy
    Horita, Yosuke
    Yamada, Y.
    Hirashima, Y.
    Kato, K.
    Nakajima, T.
    Hamaguchi, T.
    Shimada, Y.
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 65 (03) : 467 - 471
  • [44] A single-arm phase II trial of combined chemotherapy with S-1, oral leucovorin, and bevacizumab in heavily pre-treated patients with metastatic colorectal cancer
    Yamaguchi, Kazuhisa
    Taniguchi, Hiroya
    Komori, Azusa
    Narita, Yukiya
    Nitta, Sohei
    Nomura, Motoo
    Kadowaki, Shigenori
    Takahari, Daisuke
    Ura, Takashi
    Andoh, Masashi
    Muro, Kei
    Mori, Keita
    Igarashi, Yoshinori
    [J]. BMC CANCER, 2015, 15
  • [45] An Open-Label Safety Study of First-Line Bevacizumab in Combination with Standard Chemotherapy in Chinese Patients with Metastatic Colorectal Cancer Treated in an Expanded Access Program in Taiwan
    Lee, Kuan-Der
    Chen, Hong-Hwa
    Wang, Hwei-Ming
    Tsao, Chao-Jung
    Hsu, Tzu-Chi
    Chiu, Chang-Fang
    Su, Wu-Chou
    Wang, Jeng-Yi
    [J]. ONCOLOGY, 2013, 84 (05) : 299 - 304
  • [46] Phase II study of combined chemotherapy with irinotecan and S-1 (IRIS) plus bevacizumab in patients with inoperable recurrent or advanced colorectal cancer
    Komatsu, Yoshito
    Yuki, Satoshi
    Sogabe, Susumu
    Fukushima, Hiraku
    Nakatsumi, Hiroshi
    Kobayashi, Yoshimitsu
    Iwanaga, Ichiro
    Nakamura, Michio
    Hatanaka, Kazuteru
    Miyagishima, Takuto
    Kudo, Mineo
    Munakata, Masaki
    Meguro, Takashi
    Tateyama, Miki
    Sakata, Yuh
    [J]. ACTA ONCOLOGICA, 2012, 51 (07) : 867 - 872
  • [47] BODY MASS INDEX AS A PROGNOSTIC FACTOR FOR DISEASE PROGRESSION IN PATIENTS WITH METASTATIC COLORECTAL CANCER TREATED WITH BEVACIZUMAB BASED SYSTEMIC THERAPY
    Hopirtean, C.
    Ciuleanu, T.
    Cainap, C.
    Todor, N.
    Nagy, V.
    [J]. ACTA ENDOCRINOLOGICA-BUCHAREST, 2017, 13 (04) : 425 - 430
  • [48] Colonic perforation with intraluminal stents and bevacizumab in advanced colorectal cancer: retrospective case series and literature review
    Imbulgoda, Amal
    MacLean, Anthony
    Heine, John
    Drolet, Sebastien
    Vickers, Michael M.
    [J]. CANADIAN JOURNAL OF SURGERY, 2015, 58 (03) : 167 - 171
  • [49] Association of antibiotic exposure with the mortality in metastatic colorectal cancer patients treated with bevacizumab-containing chemotherapy: A hospital-based retrospective cohort study
    Lu, Linbin
    Zhuang, Tingting
    Shao, Erqian
    Liu, Yanhong
    He, Huimin
    Shu, Zhimin
    Huang, Yan
    Yao, Yichen
    Lin, Shan
    Lin, Shaoqin
    Chen, Xi
    Chen, Xiong
    [J]. PLOS ONE, 2019, 14 (09):
  • [50] Surgery with curative-intent in patients treated with first-line chemotherapy plus bevacizumab for metastatic colorectal cancer First BEAT and the randomised phase-III NO16966 trial
    Okines, A.
    Del Puerto, O.
    Cunningham, D.
    Chau, I.
    Van Cutsem, E.
    Saltz, L.
    Cassidy, J.
    [J]. BRITISH JOURNAL OF CANCER, 2009, 101 (07) : 1033 - 1038